|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/517 | |
| A61K 31/282 | |||
| A61K 31/555 | |||
| A61K 33/24 | |||
| A61K 41/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 1648465 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04743275.2 |
| Date of filing the European patent application | 2004-07-07 | |
| (97) | Date of publication of the European application | 2006-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2010-08-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2004/002932 |
| Date | 2004-07-07 |
| (87) | Number | WO 2005/004870 |
| Date | 2005-01-20 |
| (30) | Number | Date | Country code |
| 0316176 | 2003-07-10 | GB | |
| 0406546 | 2004-03-24 | GB | |
| 0407753 | 2004-04-06 | GB |
| (72) |
WEDGE, Stephen Robert, AstraZeneca R & D Alderley, GB
RYAN, Anderson Joseph, AstraZeneca R & D Alderley, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH PLATINUM COMPOUNDS AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS AND/OR INCREASED VASCULAR PERMEABILITY |
| USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH PLATINUM COMPOUNDS AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS AND/OR INCREASED VASCULAR PERMEABILITY |